188 related articles for article (PubMed ID: 28526799)
1. Acquired resistance to macrolides in
Mustafa MH; Khandekar S; Tunney MM; Elborn JS; Kahl BC; Denis O; Plésiat P; Traore H; Tulkens PM; Vanderbist F; Van Bambeke F
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28526799
[TBL] [Abstract][Full Text] [Related]
2. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
[TBL] [Abstract][Full Text] [Related]
3. Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis.
Tai AS; Kidd TJ; Whiley DM; Ramsay KA; Buckley C; Bell SC;
Pathology; 2015 Feb; 47(2):156-60. PubMed ID: 25551306
[TBL] [Abstract][Full Text] [Related]
4. Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance.
Goltermann L; Andersen KL; Johansen HK; Molin S; La Rosa R
Clin Microbiol Infect; 2022 Dec; 28(12):1594-1601. PubMed ID: 35988850
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.
Rao P; McCaughan J; McCalmont M; Goldsmith CE; Hall V; Millar BC; McCann MA; Downey DG; Rendall JC; Elborn JS; Moore JE
J Cyst Fibros; 2012 Jul; 11(4):349-52. PubMed ID: 22325689
[No Abstract] [Full Text] [Related]
6. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
8. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
[TBL] [Abstract][Full Text] [Related]
9. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M
Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751
[TBL] [Abstract][Full Text] [Related]
11. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
Strateva T; Petrova G; Mitov I
J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
[TBL] [Abstract][Full Text] [Related]
13. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
14. Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa.
Marvig RL; Søndergaard MS; Damkiær S; Høiby N; Johansen HK; Molin S; Jelsbak L
Antimicrob Agents Chemother; 2012 Aug; 56(8):4519-21. PubMed ID: 22644032
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the effect of different growth media on in vitro sensitivity to azithromycin in multi-drug resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Sörensen M; Khakimov B; Nurjadi D; Boutin S; Yi B; Dalpke AH; Eigenbrod T
Antimicrob Resist Infect Control; 2020 Dec; 9(1):197. PubMed ID: 33298147
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis.
Duong J; Booth SC; McCartney NK; Rabin HR; Parkins MD; Storey DG
PLoS One; 2015; 10(11):e0143466. PubMed ID: 26599104
[TBL] [Abstract][Full Text] [Related]
20. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
